← Deal Flow

Imperagen

Deep
2Rounds
0Articles
General InformationImperagen appears to be a deep-tech company, though specific current information about its location, employee count, and founding date could not be verified through available sources.
Funding & FinancialsFunding details for Imperagen could not be confirmed through accessible public records.
Leadership & TeamLeadership and team composition information for Imperagen is not readily available in current public sources.
Recent ActivityRecent developments or notable activities from Imperagen could not be confirmed through current web searches.

Highlights

Total Raised
—
2 rounds
Latest Round
$6.7
May 31, 2026
Stage
—
deep-tech
Employees
—
Headquarters
—
News Coverage
—
Talent Signals
—
SEC Filings
—

Backers

IQ Capital
Northern Gritstone
PXN Ventures

Funding History

$5
2026
Seed
$6.7
2026
Seed
SEC Form D   Editorial
May 31, 2026
$6.7 millionSeed · Editorial

Investors: PXN Ventures, IQ Capital, Northern Gritstone

<cite index="7-13,7-15">Imperagen, a biotech startup using quantum physics and AI to improve enzyme engineering, raised a £5 million ($6.7 million) seed round led by PXN Ventures.</cite>

May 23, 2026
£5 millionSeed · Editorial

<cite index="4-2,4-3,4-4">Imperagen uses quantum physics modeling and AI to engineer enzymes through closed-loop simulation with robots and automation, raising £5 million to advance enzyme engineering for drug development.</cite>

Similar Companies 6

Bedrock Ocean ExplorationSandboxAQSeries BGeneral IntuitionBroadcomPublicMicrosoftPublicMetaPublic